ArticleFrontiers in oncology2022

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy.

Fabian J Bolte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.